Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PULSE BIOSCIENCES, INC.PLSE · Entity 1151 | Chief Strategy Officer | September 24, 2024 | September 30, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PULSE BIOSCIENCES, INC.
Report date September 24, 2024 · Filed September 30, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,880 |
Reported balance
After 2024-09-24 transaction · row 1
1 source rowRow 1 · 2024-09-24 · Other · Acquired 3,000 · Balance 93,880 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 21,240 |
Reported balance
After 2024-09-24 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-09-24 · Other · Acquired 1,240 · Balance 21,240 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectImmediate Family Member 1 | 8,321 |
Reported balance
After 2024-09-24 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2024-09-24 · Other · Acquired 322 · Balance 8,321 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectImmediate Family Member 2 | 8,421 |
Reported balance
After 2024-09-24 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2024-09-24 · Other · Acquired 322 · Balance 8,421 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Common StockSEC Table I · non-derivative | IndirectImmediate Family Member 3 | 8,521 |
Reported balance
After 2024-09-24 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2024-09-24 · Other · Acquired 322 · Balance 8,521 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | Direct | 0 |
Reported balance
After 2024-09-24 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-09-24 · Other · Disposed 1,500 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | Direct | 0 |
Reported balance
After 2024-09-24 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-09-24 · Other · Disposed 1,500 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectSpouse | 1 |
Reported balance
After 2024-09-24 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-09-24 · Other · Disposed 620 · Balance 1 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectSpouse | 1 |
Reported balance
After 2024-09-24 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2024-09-24 · Other · Disposed 620 · Balance 1 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 1 | 0 |
Reported balance
After 2024-09-24 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 1 | 0 |
Reported balance
After 2024-09-24 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 2 | 0 |
Reported balance
After 2024-09-24 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 2 | 0 |
Reported balance
After 2024-09-24 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 3 | 0 |
Reported balance
After 2024-09-24 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
| Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2029-07-03 | IndirectImmediate Family Member 3 | 0 |
Reported balance
After 2024-09-24 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2024-09-24 · Other · Disposed 161 · Balance 0 F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.
F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 15 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 3 Disclosed balance after: 0 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 14 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 3 Disclosed balance after: 0 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 13 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 2 Disclosed balance after: 0 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 12 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 2 Disclosed balance after: 0 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 11 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 1 Disclosed balance after: 0 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 10 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 1 Disclosed balance after: 0 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 620 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 9 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 1 Underlying: Common Stock · 620 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 620 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 8 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 1 Underlying: Common Stock · 620 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 1,500 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 7 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 1,500 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · derivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 322 | $11.00 | $3,542.00 |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 3 Disclosed balance after: 8,521 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 322 | $11.00 | $3,542.00 |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 2 Disclosed balance after: 8,421 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 322 | $11.00 | $3,542.00 |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 1 Disclosed balance after: 8,321 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 1,240 | $11.00 | $13,640.00 |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 21,240 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| September 24, 2024 Filed Sep 30, 2024 19:38 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 3,000 | $11.00 | $33,000.00 |
DisclosureSEC source: 0001437749-24-030292 · rdgdoc.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,880 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 15 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 3 Disclosed balance after: 161 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 14 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 3 Disclosed balance after: 161 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 13 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 2 Disclosed balance after: 161 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 12 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 2 Disclosed balance after: 161 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 11 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 1 Disclosed balance after: 161 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 161 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 10 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 1 Disclosed balance after: 161 Underlying: Common Stock · 161 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 621 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 9 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 621 Underlying: Common Stock · 621 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 621 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 8 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 621 Underlying: Common Stock · 621 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 1,500 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 7 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseWarrant (right to buy) · Derivative | 1,500 | Not disclosed Strike: $11.00 | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · derivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2029-07-03 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 3 Disclosed balance after: 8,199 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 2 Disclosed balance after: 8,099 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member 1 Disclosed balance after: 7,999 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 1,241 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 20,000 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 21:56 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-022341 · rdgdoc.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,880 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 1,039 | $6.13 | $6,372.39 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 10 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member (4) Disclosed balance after: 1,039 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 2,400 | $5.80 | $13,926.24 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 9 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member (3) Disclosed balance after: 3,234 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 100 | $5.90 | $590.00 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 8 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member (3) Disclosed balance after: 834 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 2,400 | $5.85 | $14,029.68 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 7 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member (2) Disclosed balance after: 3,234 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 100 | $5.94 | $594.00 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member (2) Disclosed balance after: 834 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 2,300 | $5.94 | $13,661.77 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member (1) Disclosed balance after: 3,234 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 200 | $5.92 | $1,184.00 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate Family Member (1) Disclosed balance after: 934 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 5,000 | $5.94 | $29,699.50 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 9,135 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 3,800 | $5.88 | $22,344.00 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,027 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 09:10 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | PurchaseCommon Stock | 461 | $5.83 | $2,688.55 |
DisclosureSEC source: 0001437749-23-032408 · rdgdoc.xml · nonDerivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,227 Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 17:34 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $4.38 | $0.00 |
DisclosureSEC source: 0001437749-23-030246 · rdgdoc.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-11-01 F1 · derivative.exercise_date: 100% vesting upon the earlier of (i) the six (6) year anniversary of the grant date, and (ii) the 1-year anniversary of a Company change of control. Read SEC document |
| July 12, 2023 Filed Jul 14, 2023 20:25 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | GrantStock Option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $7.08 | Not disclosed |
DisclosureSEC source: 0001437749-23-019989 · rdgdoc.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-07-12 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on July 12, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to four tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $1 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone. Read SEC document |
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 143 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · derivative · entry 10 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 143 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 143 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · derivative · entry 9 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 143 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 143 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · derivative · entry 8 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 143 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 814 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · derivative · entry 7 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse Disclosed balance after: 0 Underlying: Common Stock · 814 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherWarrant (right to buy) · Derivative | 10,935 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · derivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,935 shares Expires 2027-06-09 Read SEC document |
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 143 | $2.05 | $293.15 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 734 Read SEC document |
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 143 | $2.05 | $293.15 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 734 Read SEC document |
| May 25, 2023 Filed Jun 13, 2023 17:26 UTC | PULSE BIOSCIENCES, INC. PLSE · Entity 1151 | OtherCommon Stock | 143 | $2.05 | $293.15 |
DisclosureSEC source: 0001437749-23-017296 · rdgdoc.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Immediate family member Disclosed balance after: 734 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.